From a benign nodule to Stage IIB cancer: The importance of ultrasound findings in breast pathology. Case report
Authors
DOI:
https://doi.org/10.37980/im.journal.revcog.es.20262732Keywords:
breast cancer, fine-needle aspiration biopsy, loss to follow-up, fibroadenoma, core needle biopsyAbstract
A case is presented of a 53-year-old woman with a history of a breast nodule and left-sided mastodynia of two years’ duration. Previous ultrasound studies had demonstrated a lesion suspicious for malignancy; however, two fine-needle aspiration biopsies (FNAB) yielded negative results for malignancy, leading to discharge without follow-up. One year later, the patient returned due to persistent pain. A new breast ultrasound revealed, in the upper inner quadrant of the left breast, a hypoechoic lesion with spiculated margins, antiparallel orientation, architectural distortion, and marked posterior acoustic shadowing—findings highly suggestive of malignancy, classified as BI-RADS 5 (≥95%). Mammography and core needle biopsy (CNB) were subsequently performed for histological confirmation, with results positive for invasive ductal carcinoma. This case underscores the relevance of meticulous ultrasound interpretation, the appropriate selection of the biopsy technique (avoiding fine-needle aspiration in solid lesions), the need for periodic surveillance of breast nodules even when initially deemed benign, and the value of a multidisciplinary approach in the management of complex breast pathology.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Infomedic Intl.Derechos autoriales y de reproducibilidad. La Revista RevCog es un ente académico, sin fines de lucro, que forma parte de la Sociedad Centroamericana de Ginecología y Obstetricia. Sus publicaciones son de tipo ACCESO GRATUITO y PERMANENTE de su contenido para uso individual y académico, sin restricción. Los derechos autoriales de cada artículo son retenidos por sus autores. Al Publicar en la Revista, el autor otorga Licencia permanente, exclusiva, e irrevocable a la Sociedad para la edición del manuscrito, y otorga a la empresa editorial, Infomedic International Licencia de uso de distribución, indexación y comercial exclusiva, permanente e irrevocable de su contenido y para la generación de productos y servicios derivados del mismo.




